| Translation-driven insights across the cell and gene therapy lifecycle Cell & Gene Therapy Insights is an online, open-access, peer-reviewed journal dedicated to the interdisciplinary exploration and advancement of cell and gene therapy. Through translational focus, we bridge academia and industry to support preclinical and clinical development, scale-up, and commercialization. Register below to access all of our content for free. Contact us |  |
April 2026
Upcoming webinars
New automated, closed system for cell therapy formulation and filling
Young Kim
19 May
in 14
Days
A scalable CAR-T cell manufacturing workflow producing 100+ doses per batch
Pierre Springuel, PhD, Rukmini Ladi
20 May
in 15
Days
New automated, closed system for cell therapy formulation and filling (APAC)
Young Kim
27 May
in 21
Days
Improved gene delivery and T Cell editing using cell free DNA and novel non viral delivery solutions
Claire Gueguen, PhD, Peter Archibald, PhD
27 May
in 22
Days
Cell-derived nanoparticles: a new paradigm for CAR-T cell activation and manufacturing
P Moura, B Shy, K Li et al.
28 May
in 23
Days
Accelerating success: advanced developability strategies for bioconjugates and ADCs
Yvette Stallwood, PhD, Raphael Frey, PhD
28 May
in 23
Days
Latest News
Safety assays for quality control of ATMPs: addressing mycoplasma detection challenges
Jens Björkman, Andreas Hecker
29 April
Gene therapy 2.0: genetic therapies for non-genetic disorders in neurology
Stephanie Schorge
29 April
Scale-up and process transfer considerations in lentiviral vector manufacturing
Jonathan Zmuda, Shin Kawamata
28 April
Industrializing allogeneic iPSC-derived cell therapies: challenges and solutions
Mathias Kroll, Kilian Kelly
28 April
5 ways packaging impacts cell therapy outcomes
23 April
Off‑the‑shelf and on‑target: how iPSC‑derived CAR‑T cells could democratize autoimmune cell therapy
John Goulding
14 April
Industry Insights: Regulatory dynamics and clinical progress in early 2026
Abigail Pinchbeck
8 April
Tailored analytical strategies for AAV aggregation: purpose‑driven method selection for enhanced product development
Y Zhao, L Wang, J S Reeves et al.
31 March
Advancing AAV manufacturing through platform design and process understanding
Pranav Joshi
31 March
Latest Articles
Industry Insights: From rare disease to chronic indications, cell and gene therapies broaden their impact
Abigail Pinchbeck
22 January
Advanced Therapies Week 2026
2 December 2025
Founder’s perspective: a conversation with Elisa Manzotti on 10 years of Cell & Gene Therapy Insights
Elisa Manzotti
4 November 2025
Translating both a cure and a commercialization pathway: insights into a breakthrough gene therapy company’s journey
Daniel Drozdov, Nektarios Oraiopoulos
21 January
Leaping forward: how China’s biotech evolution is capturing the in vivo CAR-T frontier
Zhenghong Gao
5 January
Scaling smarter: a case study in overcoming cell therapy manufacturing and regulatory hurdles
James Adams
18 December 2025
5 ways packaging impacts cell therapy outcomes
23 April
Building confidence in cell and gene therapy: USP’s role in an evolving therapeutic frontier
Fouad Atouf
17 March
Digitizing CMC: opportunities and constraints for artificial intelligence adoption across CGT development and manufacturing
Kumar Dhanasekharan
11 December 2025
Scale-up and process transfer considerations in lentiviral vector manufacturing
Jonathan Zmuda, Shin Kawamata
28 April
Advancing AAV manufacturing through platform design and process understanding
Pranav Joshi
31 March
Streamlined dPCR workflow for lentiviral characterization and QC of cell and gene therapies
Ruth Klaver, Miroslav Vranes, David Dobnik
9 February
Advancing cell dissociation in bioprocessing: a novel, high purity trypsin-like enzyme for GMP workflows
Tjebbe Van Der Meer
29 January
Scaling AAV5 production from bench to industrial scale: strategies for efficient, de-risked manufacturing
Sara Krekels, Anne MacIntyre
19 January
The next frontier of in vivo CAR-T: a conversation with Shon Green
Shon Green
9 January
Safety assays for quality control of ATMPs: addressing mycoplasma detection challenges
Jens Björkman, Andreas Hecker
29 April
Integration site analysis in engineered T cell therapies: what we measure, what we miss, and what regulators expect
Deividas Pazeraitis, Juozas Kupčinskas
23 February
Streamlined dPCR workflow for lentiviral characterization and QC of cell and gene therapies
Ruth Klaver, Miroslav Vranes, David Dobnik
9 February
Gene therapy 2.0: genetic therapies for non-genetic disorders in neurology
Stephanie Schorge
29 April
Advocacy at warp speed: delivering the first gene replacement therapy for SLC6A1
Amber Freed
4 February
Bringing gene therapy to the brain: Cardiff’s role in the landmark Huntington’s trial
Anne Rosser
1 December 2025
| Your life sciences content marketing partner We go beyond providing the informative content in our journals. We can help you engage your audience through tailored webinars and roundtables that generate qualified leads, showcase your company's expertise, and spark meaningful discussion on key scientific and regulatory topics. Ready to amplify your brand's impact? View our media kit |  |
| Our journals Our portfolio of four open access journals provides trusted insight across the advanced therapies landscape. Cell & Gene Therapy Insights, Bioconjugate Insights, Vaccine Insights, and Nucleic Acids Insights deliver expert commentary, original research, and practical guidance that help researchers, developers, and manufacturers stay aligned with the rapidly evolving needs of modern biomedicine. Each journal focuses on translating innovation into real-world impact, giving readers clear, actionable knowledge that supports progress from discovery through to clinical and commercial success. |  View |  View |  View |  View |
FAQ |
| Stay informed Want to keep up with the latest news in biopharma? Register for free to get the latest news, views and updates from your field. |
| Bioconjugate Insights | Cell & Gene Therapy Insights | Nucleic Acid Insights | Vaccine Insights |